FDA Import Refusal AEK-7927897-2/10002/1 — Novo Nordisk
The FDA refused shipment AEK-7927897-2/10002/1 from Novo Nordisk (United Kingdom) on Nov 17, 2025. The refused product falls under Drugs and Biologics — SEMAGLUTIDE (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Nov 17, 2025
- Country
- United Kingdom
- Product Category
- Drugs and Biologics
- Product Code
- 61PAK72 SEMAGLUTIDE (ANTI-DIABETIC)
- Charges
- 75